LicianPro

GTBP news · GTBP stock

GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting

Yahoo Finance · Oct 26, 2026 · GT Biopharma Inc (GTBP)

SAN FRANCISCO, CALIFORNIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced that it has been selected for an oral presentation at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting taking place from November 4-8, 2026 in Phoenix, AZ. Oral Presentation Details

Original at Yahoo Finance

Not investment advice. Headline and summary only, not a full reprint.